Skip to main content
. 2017 Oct 10;7:12916. doi: 10.1038/s41598-017-13365-5

Figure 5.

Figure 5

Sodium fluorocitrate reduces cellular uptake of palmitate in INS-1 cells. (a) INS-1 cells were treated with 0.2 mM sodium fluorocitrate (SFC) in the presence or absence of 0.4 mM palmitate (PA) for indicated time period. Oxygen consumption rate (OCR) of palmitate as a carbon substrate was determined by using Seahorse XF24 extracellular analyzer. Data are presented as mean ± SE from three independent experiments and analyzed by two-way ANOVA. **p < 0.01; ***p < 0.001 vs. palmitate-treated INS-1 cells. INS-1 cells were treated with 0.2 mM sodium fluorocitrate (SFC) (b) or 0.4 mM sulfo-N-succinimidyl oleate (SSO) (c) in the presence or absence of 0.4 mM palmitate (PA) for indicated time period. After treating with [14C]-palmitate for 30 min, radioactivities of [14C]-palmitate in cells were measured by using a beta counter. Data are expressed as mean ± SE and analyzed by two-way ANOVA. ***p < 0.001 vs. palmitate-treated INS-1 cells. (d) INS-1 cells were treated with 0.4 mM of palmitate in the presence of SSO for indicated time period. Levels of cleaved caspase 3 (C-Cas3) were analyzed by immunoblotting with anti-caspase 3 antibodies. Full size original blots are presented in supplementary Fig. S6. Data are presented as mean ± SE and analyzed by two-way ANOVA. ***p < 0.001 vs. DMSO-treated INS-1 cells.